Variant report
Variant | esv3354250 |
---|---|
Chromosome Location | chr4:187846708-187848206 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs77636219 | chr4:187846719-187846720 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536405047 | chr4:187846723-187846724 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs564812689 | chr4:187846776-187846777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532291887 | chr4:187846781-187846782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs4861730 | chr4:187846794-187846795 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs140456439 | chr4:187846915-187846916 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs112374527 | chr4:187846924-187846925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs72496345 | chr4:187846930-187846931 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs534084718 | chr4:187846955-187846956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs376750653 | chr4:187847009-187847010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs543938729 | chr4:187847037-187847038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563733824 | chr4:187847051-187847052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs570934627 | chr4:187847092-187847093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7665481 | chr4:187847112-187847113 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs543174783 | chr4:187847201-187847202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10634539 | chr4:187847224-187847225 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs33926387 | chr4:187847225-187847226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559667165 | chr4:187847236-187847237 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs530448026 | chr4:187847255-187847256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs10634540 | chr4:187847284-187847285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs33991898 | chr4:187847285-187847286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538083946 | chr4:187847289-187847290 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527330610 | chr4:187847338-187847339 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs199939408 | chr4:187847385-187847386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs528813867 | chr4:187847458-187847459 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10634541 | chr4:187847459-187847460 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs556383378 | chr4:187847463-187847464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs367678788 | chr4:187847464-187847465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376511746 | chr4:187847465-187847466 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs537664982 | chr4:187847469-187847470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs374048645 | chr4:187847478-187847479 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7670870 | chr4:187847479-187847480 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs7695552 | chr4:187847480-187847481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7671012 | chr4:187847486-187847487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs570955619 | chr4:187847490-187847491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs7670879 | chr4:187847491-187847492 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs7670916 | chr4:187847554-187847555 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs574644447 | chr4:187847568-187847569 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112412647 | chr4:187847603-187847604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs13117841 | chr4:187847604-187847605 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs553486203 | chr4:187847605-187847606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146791072 | chr4:187847618-187847619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149162221 | chr4:187847624-187847625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566540204 | chr4:187847632-187847633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372774834 | chr4:187847715-187847716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538982458 | chr4:187847768-187847769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs147315241 | chr4:187847778-187847779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs6553024 | chr4:187847786-187847787 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs144828535 | chr4:187847855-187847856 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs138680536 | chr4:187847864-187847865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187837200-187863800 | Weak transcription | Right Atrium | heart |
2 | chr4:187840000-187853400 | Weak transcription | Fetal Kidney | kidney |
3 | chr4:187842000-187852400 | Weak transcription | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
4 | chr4:187842600-187848600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr4:187842600-187852200 | Weak transcription | HMEC | breast |
6 | chr4:187845400-187846800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
7 | chr4:187845800-187851200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
8 | chr4:187846000-187850400 | Weak transcription | Muscle Satellite Cultured Cells | -- |
9 | chr4:187846200-187847800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr4:187846200-187848600 | Weak transcription | NHEK | skin |
11 | chr4:187846200-187851400 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
12 | chr4:187846200-187851800 | Weak transcription | Osteobl | bone |
13 | chr4:187846400-187848600 | Weak transcription | NHDF-Ad | bronchial |
14 | chr4:187846400-187849800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
15 | chr4:187846400-187851200 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
16 | chr4:187846400-187851200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
17 | chr4:187846400-187853400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
18 | chr4:187846800-187848600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
19 | chr4:187847800-187848800 | Enhancers | Breast Myoepithelial Primary Cells | Breast |